Application of next-generation sequencing in the treatment of myelodysplastic syndrome: from mechanisms to clinical practice
{{output}}
Myelodysplastic syndrome (MDS) is a malignant clonal disorder originating from hematopoietic stem and progenitor cells and is characterized by ineffective hematopoiesis and a high propensity for transformation into acute leukemia. Research has indicated that t... ...
